Tavros Therapeutics, Inc. — Form D
Tavros Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-17. The offering totals $3.0M, of which $1000K was reported sold. Industry: Other Technology.
Offering
- Filed: 2020-03-17
- Form: D
- Accession: 0001806643-20-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1000K
- Remaining: $2.0M
- Investors: 1
- Date of first sale: 2020-03-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-363041
Issuer
- Name: Tavros Therapeutics, Inc.
- CIK: 0001806643
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 701 WEST MAIN ST., SUITE 200, DURHAM, NC, 27701
- Phone: 919-602-2631
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Eoin McDonnell | Director | Durham, NC |
| Kris Wood | Director | Durham, NC |
| Eoin McDonnell | Executive Officer | Durham, NC |
More